MGNX
Price
$1.71
Change
-$0.04 (-2.29%)
Updated
Feb 4, 02:53 PM (EDT)
Capitalization
110.7M
15 days until earnings call
Intraday BUY SELL Signals
SMMT
Price
$14.23
Change
-$0.36 (-2.47%)
Updated
Feb 4, 03:18 PM (EDT)
Capitalization
10.86B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MGNX vs SMMT

Header iconMGNX vs SMMT Comparison
Open Charts MGNX vs SMMTBanner chart's image
MacroGenics
Price$1.71
Change-$0.04 (-2.29%)
Volume$2.1K
Capitalization110.7M
Summit Therapeutics
Price$14.23
Change-$0.36 (-2.47%)
Volume$3.8K
Capitalization10.86B
MGNX vs SMMT Comparison Chart in %
MGNX
Daily Signal:
Gain/Loss:
SMMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MGNX vs. SMMT commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGNX is a Hold and SMMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (MGNX: $1.75 vs. SMMT: $14.59)
Brand notoriety: MGNX and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGNX: 36% vs. SMMT: 126%
Market capitalization -- MGNX: $110.7M vs. SMMT: $10.86B
MGNX [@Biotechnology] is valued at $110.7M. SMMT’s [@Biotechnology] market capitalization is $10.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGNX’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 1 green FA rating(s).

  • MGNX’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMT is a better buy in the long-term than MGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGNX’s TA Score shows that 5 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • MGNX’s TA Score: 5 bullish, 5 bearish.
  • SMMT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MGNX and SMMT are a good buy in the short-term.

Price Growth

MGNX (@Biotechnology) experienced а -4.89% price change this week, while SMMT (@Biotechnology) price change was -8.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

MGNX is expected to report earnings on Feb 19, 2026.

SMMT is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($10.9B) has a higher market cap than MGNX($111M). MGNX YTD gains are higher at: 8.696 vs. SMMT (-16.581). MGNX has higher annual earnings (EBITDA): -63.11M vs. SMMT (-921.45M). SMMT has more cash in the bank: 239M vs. MGNX (146M). SMMT has less debt than MGNX: SMMT (5.43M) vs MGNX (37M). MGNX has higher revenues than SMMT: MGNX (126M) vs SMMT (0).
MGNXSMMTMGNX / SMMT
Capitalization111M10.9B1%
EBITDA-63.11M-921.45M7%
Gain YTD8.696-16.581-52%
P/E RatioN/A26.36-
Revenue126M0-
Total Cash146M239M61%
Total Debt37M5.43M682%
FUNDAMENTALS RATINGS
MGNX vs SMMT: Fundamental Ratings
MGNX
SMMT
OUTLOOK RATING
1..100
2468
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
5289
P/E GROWTH RATING
1..100
949
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGNX's Valuation (81) in the Biotechnology industry is in the same range as SMMT (93). This means that MGNX’s stock grew similarly to SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as MGNX (100). This means that SMMT’s stock grew similarly to MGNX’s over the last 12 months.

MGNX's SMR Rating (98) in the Biotechnology industry is in the same range as SMMT (100). This means that MGNX’s stock grew similarly to SMMT’s over the last 12 months.

MGNX's Price Growth Rating (52) in the Biotechnology industry is somewhat better than the same rating for SMMT (89). This means that MGNX’s stock grew somewhat faster than SMMT’s over the last 12 months.

SMMT's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for MGNX (94). This means that SMMT’s stock grew significantly faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGNXSMMT
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
MGNX
Daily Signal:
Gain/Loss:
SMMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
UTSL41.521.80
+4.53%
Direxion Daily Utilities Bull 3X ETF
FTKI19.480.03
+0.16%
First Trust Small Cap Buywrite Income ETF
MNA36.110.03
+0.08%
NYLI Merger Arbitrage ETF
FRDD18.86N/A
N/A
Direxion Daily F Bear 1X ETF
PSI93.88-1.44
-1.51%
Invesco Semiconductors ETF

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
N/A
CRBU - MGNX
52%
Loosely correlated
+6.85%
BEAM - MGNX
50%
Loosely correlated
-0.11%
FATE - MGNX
47%
Loosely correlated
-5.69%
IMVT - MGNX
46%
Loosely correlated
-1.07%
IDYA - MGNX
46%
Loosely correlated
+0.50%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
+3.77%
BCDA - SMMT
70%
Closely correlated
-4.13%
BNTX - SMMT
53%
Loosely correlated
-0.58%
TIL - SMMT
44%
Loosely correlated
-1.66%
IDYA - SMMT
44%
Loosely correlated
+0.50%
MGNX - SMMT
43%
Loosely correlated
N/A
More